Equity Holdings of Nippon India Pharma Fund
Here is the most recent list of
equity holdings in the Nippon India Pharma Fund's portfolio
as of 31 Dec 2025 . The fund's AUM is 6,891.31 crores, of which equity holdings constitute 97.37%.
| Name of the Equity | Holding Percentage |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | 13.02% |
| LUPIN LTD. | 7.36% |
| DIVI'S LABORATORIES LTD. | 6.58% |
| CIPLA LTD. | 6.39% |
| APOLLO HOSPITALS ENTERPRISE LTD. | 5.53% |
| Vijaya Diagnostic Centre Ltd | 3.71% |
| Medplus Health Services Ltd | 3.54% |
| AJANTA PHARMA LTD. | 3.21% |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD. | 2.73% |
| ABBOTT INDIA LTD. | 2.61% |
| AUROBINDO PHARMA LTD. | 2.44% |
| Thyrocare Technologies Ltd | 2.37% |
| Dr. Lal PathLabs Ltd | 2.19% |
| Alkem Laboratories Ltd | 2.16% |
| Narayana Hrudayalaya Ltd | 2.12% |
| IPCA LABORATORIES LTD. | 2.05% |
| PFIZER LTD. | 1.92% |
| Gland Pharma Ltd | 1.67% |
| FORTIS HEALTHCARE LTD. | 1.18% |
| Sanofi India Ltd | 1.14% |
| Max Healthcare Institute Ltd | 1.13% |
| Syngene International Ltd | 1.09% |
| BIOCON LTD. | 1.06% |
| ASTRAZENECA PHARMA INDIA LTD. | 0.68% |
| INDOCO REMEDIES LTD. | 0.52% |
| Orchid Pharma Ltd | 0.42% |